Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naomi Lowy
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
OpenAlex ID:
A5016879216
Enhancing Insights into Pulmonary Vascular Disease Through a Precision Medicine Approach. A Joint NHLBI–Cardiovascular Medical Research and Education Fund Workshop Report
2017
·
John H. Newman
, Stuart Rich
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
79
Endpoints in Heart Failure Drug Development
2020
·
Mona Fiuzat
, Naomi Lowy
, et al.
·
JACC Heart Failure
·
54
PDF
Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA’s Role in Ensuring Patient Safety
2016
·
Jonathan P. Jarow
, Steven Lemery
, et al.
·
Therapeutic Innovation & Regulatory Science
·
31
Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism
2018
·
Manoj Khurana
, Immo Zadezensky
, et al.
·
Clinical Pharmacology & Therapeutics
·
19
US Food and Drug Administration and Representation of Older Adults in Clinical Trials
2016
·
Naomi Lowy
, John Whyte
·
Journal of Clinical Oncology
·
4
The Integrated Review: FDA Modernizes the Review of New Drug Marketing Applications
2020
·
Rhonda M. Hearns-Stewart
, John Farley
, et al.
·
Therapeutic Innovation & Regulatory Science
·
3
Correction to: The Integrated Review: FDA Modernizes the Review of New Drug Marketing Applications
2020
·
Rhonda M. Hearns-Stewart
, John Farley
, et al.
·
Therapeutic Innovation & Regulatory Science
PDF
Show more works
View as search
Works count:
7
Citation count:
190
H-index:
4
I10-index:
4
Year
Topic
Type